<DOC>
	<DOCNO>NCT00096837</DOCNO>
	<brief_summary>The purpose study determine drug motexafin gadolinium effective treatment patient relapse refractory multiple myeloma .</brief_summary>
	<brief_title>A Study Motexafin Gadolinium Treatment Relapsed Refractory Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<criteria>Relapsed Refractory Multiple Myeloma ≥ 18 year old Able provide consent participation ECOG status 02 Lab value : ANC ≥ 1,000/µL WBC count ≥ 2.0/µL Hemoglobin ≥ 8.0 g/dL Platelet count ≥ 50,000/µL AST ALT ≤ 2 x ULN Total Bilirubin ≤ 2 x ULN Creatinine ≤ 2.0 mg/dL Not pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Myeloma</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Relapsed Multiple Myeloma</keyword>
	<keyword>Refractory Multiple Myeloma</keyword>
</DOC>